Alphadyne Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$11.2M |
| 2 |
SPDR Gold Trust
GLD
|
+$7.34M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$967K |
| 4 |
iShares US Home Construction ETF
ITB
|
+$923K |
| 5 |
PayPal
PYPL
|
+$421K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares China Large-Cap ETF
FXI
|
+$181M |
| 2 |
Alibaba
BABA
|
+$144M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$780K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 0.59% |
| 2 | Technology | 0.2% |
| 3 | Healthcare | 0.15% |
| 4 | Consumer Staples | 0.08% |
| 5 | Financials | 0.08% |
Similar funds
Alphadyne Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Alphadyne Asset Management held 172 positions worth $549M, down 55% from $1.21B the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Alphadyne Asset Management withdrew a net $671M in Q2 2025, closing 6 positions and reducing 6 holdings. Its most notable exit was Invesco S&P 500 Equal Weight ETF, an estimated $780K position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 0.59% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Alphadyne Asset Management opened a new position in Invesco QQQ Trust worth $12.4M.
- Alphadyne Asset Management's largest Q2 2025 buy was Invesco QQQ Trust: 22,536 shares worth $12.4M.
- Alphadyne Asset Management's biggest Q2 2025 reduction was iShares China Large-Cap ETF, cutting an estimated $181M.
- Alphadyne Asset Management fully exited Invesco S&P 500 Equal Weight ETF in Q2 2025, selling an estimated $780K.
- Alphadyne Asset Management's ten largest holdings make up 80% of its $549M portfolio in Q2 2025.
- Alphadyne Asset Management opened 156 new positions and closed 6 in Q2 2025.
- Alphadyne Asset Management's portfolio value fell 55% quarter-over-quarter to $549M.
Based on Alphadyne Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.